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INTRODUCTION:  The  spleen  is a highly  vascular  organ  and  is  in  close  proximity  to  many  potential  primary
sites  such  as  the stomach,  breast,  pancreas  and  colon.  It is however  an  unusual  site  for  metastatic  disease.
The  reasons  for this  are  not  fully  understood  at the present  time.  A number  of hypotheses  have  been
postulated.  Deﬁnitive  diagnosis  and  subsequent  treatment  of  metastatic  disease  to  the  spleen  presents
a  number  of  challenges  for the  surgeon  and  the  wider  multi  disciplinary  team.
PRESENTATION OF  CASE:  A  60 year  old  male  presented  with  a three  week  history  of  lower  abdominal  pain,
distension,  nausea  and  a palpable  mass  in  the right  iliac  fossa.  Imaging  revealed  a large  circumferential
caecal  mass  consistent  with  malignancy  with  secondary  small  bowel  obstruction.  The  patient  underwent
an  emergency  right  hemicolectomy  and was subsequently  treated  with systemic  chemotherapy  for  lymph
node  positive  caecal  adenocarcinoma.  Two  years  following  initial  presentation,  two  suspicious  lesions
were  noted  within  the  spleen  during routine  surveillance  imaging  with  computerised  tomography  of
the  thorax,  abdomen  and  pelvis.  Of note,  one  month  prior  to this  the  patient  had  a normal  surveillance
colonoscopy  performed  with  multiple  interval  carcinoembryonic  antigen  (CEA)  levels  recorded  within
the  normal  range.  Image  guided  splenic  biopsy  and subsequent  histology  conﬁrmed  metastatic  caecal
adenocarcinoma.
DISCUSSION:  Splenic  metastases  from  any  source  including  the  colon  are  a rare  phenomenon.
CONCLUSION: This  case  questions  the  value  of routine  post  operative  CEA  monitoring,  underlines  the
importance  of multimodal  pathways  of surveillance  and  highlights  recent  advances  in  image  guided
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. Introduction
Metastases to the spleen from various sites are a rare occur-
ence and usually occur in the presence of widely disseminated
isease.1 Previously documented sites of primary disease include
he ovaries, melanoma, breast, lung and the colon and are typically
ssociated with high disease burden. Splenic metastases from the
olon involving low levels of disease burden are rare in the liter-
ture and to date, there have been only two documented cases of
etastases to the spleen originating from a caecal tumour2,3.. Case report
A 60 year old male with no signiﬁcant past medical history pre-
ented to the emergency department with a three week history of
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lower abdominal pain, nausea and a palpable mass in the right iliac
fossa. Computerised tomography (CT) of the abdomen and pelvis
demonstrated a large circumferential obstructing tumour of the
caecum without evidence of distant metastases (Fig. 1). The patient
was prepared for surgery, consisting of a right hemicolectomy with
an uncomplicated postoperative course. Histology from the excised
specimen revealed a poorly differentiated adenocarcinoma with
signet ring cell permeation through the muscularis propria. Lymph
node analysis comprised twenty one lymph nodes, all noted to
contain metastatic spread. Additional CT of thorax performed in
the post operative period was reported as normal. The presenting
tumour was therefore classiﬁed pathologically as stage III caecal
adenocarcinoma (pT3N2M0). Carcinoembryonic antigen measured
prior to surgery was recorded within normal limits (3 ng/L).
Two months post surgical resection, the patient underwent
adjuvant chemotherapy utilising the FOLFOX protocol as dis-
cussed at the multidisciplinary conference. He received 12 cycles of
Open access under CC BY-NC-ND license.chemotherapy however the dose of oxaliplatin was reduced after
cycle six due to development of thrombocytopaenia and a slight rise
in CEA level, both of which were attributed to the chemotherapeutic
agent (Table 1). He completed his course of adjuvant chemother-
apy eight months after initial presentation. The patient was then
s Ltd.  Open access under CC BY-NC-ND license. 
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Fig. 1. CT image at presentation demonstrating a large caecal neoplasm with con-
current small bowel obstruction.
Table 1
Surveillance.
Test Result (ng/ml)
CEA June 2011 3
CEA October 2011 6
CEA November 2011 5.2
CEA January 2012 5.7
Restaging CT May 2012 No evidence of metastatic disease
CEA May 2012 2.4
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In most of the reported cases of colorectal metastases to theColonoscopy Normal
Follow up CT May  2013 Two splenic lesions
ntered into a standard programme of routine surveillance con-
isting of regular clinical reviews, interval measurement of CEA
evels, colonoscopy and yearly CT of thorax, abdomen and pelvis.
lthough surveillance studies proved negative initially for disease
ecurrence, a routine CT thorax, abdomen and pelvis at twenty
hree months post initial presentation revealed left sided para
Fig. 2. Surveillence CT demostrating a normal CT in May  2012PEN  ACCESS
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aortic lymphadenopathy and two  suspicious splenic lesions mea-
suring 2.7 × 2.5 cm and 2.4 × 2.2 cm respectively which were not
present on imaging, performed twelve months previously (Fig. 2 A
and B). The patient was completely asymptomatic at the time of
metastatic presentation.
The splenic lesions were biopsied under ultrasound guidance
using an 18 gauge tru cut needle without complication (Fig. 3). Sub-
sequent histology of the biopsied lesions revealed normal splenic
parenchyma inﬁltrated by poorly differentiated adenocarcinoma
with abundant signet ring cells, morphologically identical to the
initial presentation with an obstructing caecal tumour (Fig. 3C).
Further discussion at the multidisciplinary conference ensued. The
disease although of low burden and primarily localised to the
spleen was associated with the presence of suspicious para aortic
lymphadenopathy prompting chemotherapy rather than opera-
tive intervention. The oncology team advised further systemic
chemotherapy comprising 5 – ﬂuorouracil, oxaliplatin and avastin.
The patient remains well on chemotherapy and further imaging
studies are planned in 4 months time to assess response to treat-
ment.
3. Discussion
Metastases to the spleen from any primary tumour are rare
despite the highly vascular nature of the organ and it’s proximity to
many potential primary sites including the pancreas, stomach, lung,
breast and the colon. A number of theories have been put forward
to explain the “hostile” nature of the spleen preventing tumour
implantation and proliferation of neoplastic cells. These encom-
pass intrinsic anatomical, histological and immunological features
of the spleen.4,5 Anatomical features thought to play a role include
the sharp angle at the origin of the splenic artery with the coeliac
axis, the rhythmic contraction of splenic sinusoids and the scarcity
of lymphatic vessels extending to the intrasplenic parenchyma.
Immunological factors considered to negatively impact on the rate
of malignant cell implantation include the presence of abundant
kupffer cells, immunoglobin synthesis and opsonin production.spleen, the primary tumour is located on the left side of the colon
or in the rectum.6 This distribution of colorectal metastases favours
the theory that neoplastic cells reach the spleen via retrograde
 and abnormal CT with two  splenic lesions 1 year later.
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mig. 3. US biopsy of splenic lesion demostrating biopsy needle through the metas
isease.
issemination through the inferior mesenteric vein.7 To the best of
ur knowledge, there have been only two previous cases of caecal
denocarcinoma metastasising to the spleen recorded in the litera-
ure without inﬁltration of other solid organs.2,3 Furthermore, there
ave only been 4 additional cases of right sided colonic cancer (all
scending colon) with metastases to the spleen recorded.6 Given
he additional presence of left sided para aortic lymphadenopathy
n our patient, this could possibly indicate tumour spread via the
ymphatic system.
Carcinoemryonic antigen (CEA) is an oncofoetal protein used
s a tumour marker. It is not routinely used as a screening tool
s it lacks sensitivity and speciﬁcity. However it is widely used
s part of surveillance programmes to monitor for disease recur-
ence in conjunction with colonoscopy, imaging and follow up
linic appointments. It has been shown that in 30–40% of cases
f disease recurrence there is no corresponding rise in CEA levels.8
urthermore in cases where CEA levels were recorded as normal at
nitial presentation, it was reported that in cases of recurrence, a
orresponding elevation in CEA is only observed in 27% of cases.9 In
ne large study, it was noted that CEA monitoring did not result in
mproved survival.10 This brings into question the value of interval
EA monitoring as part of surveillance programmes post resection
or colorectal cancers.
Historically the technique of percutaneous splenic biopsy was
ot widely performed due to the perceived high complication rates
ostly involving haemorrhage. With the advent of improved imag-
ng modalities, splenic biopsies can now be performed relatively
afely using either ultrasound or CT guided techniques. Ultrasound
s currently favoured over CT due to the real time images projected.
he differential of a solid splenic lesion includes metastases, an
nfarct or a splenic abscess. Adequate collection of targeted tissue
uitable for histological analysis has been recorded at 88% in one
eries. Complication rates were found to be directly proportional
o the gauge of needle used in the procedure.11
Given the limited number of cases recorded in the literature,
he optimal treatment for splenic metastases from a colorectal pri-
ary is not known. In cases of isolated splenic metastases from adeposit and the histology slide displaying histological conﬁrmation of metastatic
colonic source, splenectomy is preferred to chemo/radio therapy.
In the literature, this has been performed by both the traditional
open technique and more recently laparoscopically.12 To date dis-
ease free intervals and survival are reported to be similar for both
techniques. Chemotherapy is currently favoured in circumstances
where disease is recorded in other sites including the spleen. The
current data available is too small to draw any deﬁnitive conclu-
sions regarding the optimal treatment for splenic metastases in the
context of low disease burden.
4. Conclusion
This case illustrates a number of important features regarding
splenic metastates from caecal carcinoma. Firstly, multimodal
imaging is important in the context of asymptomatic patients and
especially given the limited sensitivity of CEA meaurements. Sec-
ond, modern image guided biopsy techniques facilitate accurate
and safe percutaneous biopsy of suspicious splenic lesions. Third,
further research is necessary to determine the optimal treatment
of splenic metastases from a colonic source with a low disease
burden.
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